Association between Air Pollutants and Initiation of Biological Therapy in Patients with Ankylosing Spondylitis: A Nationwide, Population-Based Case-Control Study

Author:

Kao Chung-Mao1,Chen Yi-Ming1,Huang Wen-Nan1,Chen Yi-Hsing1,Chen Hsin-Hua1

Affiliation:

1. Taichung Veterans General Hospital

Abstract

Abstract Background: Outdoor air pollution has been found to trigger systemic inflammatory responses and aggravate the activity of certain rheumatic diseases. However, few studies have explored the influence of air pollution on the activity of ankylosing spondylitis (AS). As patients with active AS in Taiwan can be reimbursed through the National Health Insurance program for biological therapy, we investigated the association between air pollutants and the initiation of biologics for active disease in patients with AS. Methods: Since 2011, hourly concentrations of ambient air pollutants, including PM2.5, PM10, NO2, CO, SO2 and O3 have been estimated in Taiwan. Using Taiwanese National Health Insurance Research Database, we identified patients with newly diagnosed AS from 2003 to 2013. We selected 584 patients initiating biologics from 2012 to 2013 and 2,336 gender-, age at biologic initiation-, year of AS diagnosis- and disease duration-matched controls. We examined the associations of biologics initiation with air pollutants exposure within one year prior to biologic use while adjusting for potential confounders, including disease duration, urbanisation level, monthly income, Charlson comorbidity index (CCI), uveitis, psoriasis, inflammatory bowel disease and the use of medications for AS. Results are shown as adjusted odds ratio (aOR) with 95% confidence intervals (CIs). Results: The initiation of biologics was associated with exposure to CO (per 1 ppm) (aOR, 8.58; 95% CI, 2.02–36.35), and NO2 (per 10 ppb) (aOR, 0.23; 95% CI, 0.11–0.50). Other independent predictors included disease duration (incremental year, aOR, 8.97), CCI (aOR, 1.31), psoriasis (aOR, 25.06), use of non-steroidal anti-inflammatory drugs (aOR, 23.66), methotrexate use (aOR, 4.53; 95% CI, 2.93–7.00), sulfasalazine use (aOR, 12.15; 95% CI, 8.98–15.45) and prednisolone equivalent dosages (mg/day, aOR, 1.11). Conclusions: This nationwide, population-based study revealed that the initiation of biologics was positively associated with CO levels, but negatively associated with NO2 levels.

Publisher

Research Square Platform LLC

Reference50 articles.

1. Social economic costs of ankylosing spondylitis in Spain;Merino M;Clinical and experimental rheumatology,2021

2. Using Self-Reported Patient Experiences to Understand Patient Burden: Learnings from Digital Patient Communities in Ankylosing Spondylitis;Sunkureddi P;Adv Ther,2018

3. FRI0428†࿽Epidemiology of Ankylosing Spondylitis in Taiwan: A Nationwide Population Study;Hsieh M-Y;Annals of the Rheumatic Diseases,2016

4. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update;Ramiro S;Ann Rheum Dis,2022

5. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants;Hiraiwa K;Mediators Inflamm,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3